Portfoliotracker

Vetoquinol SA

VETO.PA · PARIS · Healthcare Drug Manufacturers - Specialty & Generic 86/100 A

86,35 €
▼ −1,15 (−1,31 %)
Trading delayed by 15 min
Price as of 17. 11. 16:50, fetched 17. 11. 17:14
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score86 / 100 Market cap1,02 mld. € P/E16,1 Forward P/E15,6 P/S1,9 P/B1,7 EV/EBITDA6,5 Dividend yield1,06 % FCF yield7,85 % EPS5,44 € Net margin11,9 % Return on equity10,7 % Beta0,77 Debt / equity0,02
52-week range 65,70 to 91,50
3-month average volume0,0 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA operates as a subsidiary of Soparfin SCA.

Employees
2 526
Country
France
Data since
17. 11. 2006

Explore further

Similar companies VIRP.PARBT.PATHEP.PANRO.PAWAVE.PA

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account